Impact of 18F-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial

被引：7

作者：

Teoh, E. ^{[1
]}

Bottomley, D. ^{[2
]}

Scarsbrook, A. ^{[2
]}

Payne, H. ^{[3
]}

Afaq, A. ^{[3
]}

Bomanji, J. ^{[3
]}

van As, N. ^{[4
]}

Chua, S. ^{[4
]}

Hoskin, P. ^{[5
]}

Chambers, A. ^{[5
]}

Cook, G. J. ^{[6
]}

Warbey, V. S. ^{[6
]}

Chau, A. ^{[7
]}

Ward, P. ^{[7
]}

Miller, M. P. ^{[7
]}

Stevens, D. J. ^{[7
]}

Wilson, L. ^{[7
]}

Gleeson, F. V. ^{[1
]}

机构：

[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[3] UCL, London, England

[4] Royal Marsden NHS Fdn Trust, London, England

[5] Mt Vernon Canc Ctr, London, England

[6] Kings Coll London, London, England

[7] Blue Earth Diagnost, Oxford, England

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 05期

关键词：

D O I：

10.1016/j.ijrobp.2017.09.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA-8

引用

页码：1316 / 1317

页数：3